Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR5T3 OR8D1 OR9G1 GPR22 OR4D10 OR13F1 ADGRG1 GPRC5A OR10D3 OR51A7 ADRA2A ADRA2B ADRA2C OXTR OR56B1 P2RY2 ADGRG2 ADGRF5 CCR4 GPRC5D GPR171 ADGRD2 ADGRL2 OR51V1 ADGRF1	5.00e-09	884	145	25	GO:0004930
GeneOntologyMolecularFunction	alpha2-adrenergic receptor activity	ADRA2A ADRA2B ADRA2C	3.75e-07	3	145	3	GO:0004938
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	OR5T3 OR8D1 OR9G1 GPR22 OR4D10 OR13F1 ADGRG1 GPRC5A PKD1L3 OR10D3 OR51A7 MET ADRA2A ADRA2B ADRA2C OXTR OR56B1 P2RY2 ADGRG2 ADGRF5 CCR4 GPRC5D GPR171 ADGRD2 ADGRL2 OR51V1 ADGRF1	1.39e-06	1353	145	27	GO:0004888
GeneOntologyMolecularFunction	epinephrine binding	ADRA2A ADRA2B ADRA2C	7.38e-06	6	145	3	GO:0051379
GeneOntologyMolecularFunction	alpha-adrenergic receptor activity	ADRA2A ADRA2B ADRA2C	7.38e-06	6	145	3	GO:0004936
GeneOntologyMolecularFunction	adrenergic receptor activity	ADRA2A ADRA2B ADRA2C	4.34e-05	10	145	3	GO:0004935
GeneOntologyMolecularFunction	catecholamine binding	ADRA2A ADRA2B ADRA2C	1.02e-04	13	145	3	GO:1901338
GeneOntologyMolecularFunction	ubiquitin-like protein transferase activity	TRIM61 UBR4 C10orf90 ZMIZ1 TRIP12 TRIM59 FBXO10 TRIM9 ZMIZ2 HERC2 HERC1 WDR24	3.67e-04	512	145	12	GO:0019787
GeneOntologyMolecularFunction	aminoacyltransferase activity	TRIM61 UBR4 C10orf90 ZMIZ1 TRIP12 TRIM59 FBXO10 TRIM9 ZMIZ2 HERC2 HERC1 WDR24	5.16e-04	532	145	12	GO:0016755
GeneOntologyMolecularFunction	ubiquitin-like protein ligase activity	TRIM61 UBR4 C10orf90 ZMIZ1 TRIP12 TRIM59 TRIM9 ZMIZ2 HERC2 WDR24	6.70e-04	398	145	10	GO:0061659
GeneOntologyMolecularFunction	zinc ion binding	CYLD EPRS1 ZSWIM8 TRIM61 UBR4 ZNF407 ZMIZ1 TRIP12 TRIM59 ZRANB3 TRIM9 ZMIZ2 POLR1B HERC2 NR1I3 RABGGTB	7.66e-04	891	145	16	GO:0008270
GeneOntologyBiologicalProcess	regulation of uterine smooth muscle contraction	ADRA2A ADRA2B ADRA2C OXTR	9.93e-07	12	141	4	GO:0070472
GeneOntologyBiologicalProcess	receptor transactivation	ADRA2A ADRA2B ADRA2C	1.24e-06	4	141	3	GO:0035624
GeneOntologyBiologicalProcess	uterine smooth muscle contraction	ADRA2A ADRA2B ADRA2C OXTR	1.43e-06	13	141	4	GO:0070471
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	OR5T3 OR8D1 OR9G1 GPR22 OR4D10 OR13F1 ADGRG1 GPRC5A OR10D3 OR51A7 MET ADRA2A ADRA2B ADRA2C OXTR OR56B1 P2RY2 ADGRG2 ADGRF5 CCR4 GPRC5D GPR171 ADGRD2 ADGRL2 OR51V1 ADGRF1	2.55e-06	1395	141	26	GO:0007186
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	CYLD ZSWIM8 KLHL24 SLF1 TRIM61 UBR4 C10orf90 COPS3 ZMIZ1 FANCM TRIP12 TRIM59 BAP1 FBXO10 TRIM9 ZMIZ2 KBTBD13 HERC2 HERC1 CDC20 WDR24	5.08e-06	1009	141	21	GO:0070647
GeneOntologyBiologicalProcess	adenylate cyclase-activating G protein-coupled receptor signaling pathway	ADGRG1 ADRA2A ADRA2B ADRA2C ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	6.78e-06	191	141	9	GO:0007189
GeneOntologyBiologicalProcess	protein modification by small protein conjugation	ZSWIM8 KLHL24 SLF1 TRIM61 UBR4 C10orf90 COPS3 ZMIZ1 FANCM TRIP12 TRIM59 FBXO10 TRIM9 ZMIZ2 KBTBD13 HERC2 HERC1 CDC20 WDR24	1.10e-05	893	141	19	GO:0032446
GeneOntologyBiologicalProcess	post-translational protein modification	CYLD ZSWIM8 KLHL24 SLF1 TRIM61 UBR4 C10orf90 COPS3 ZMIZ1 FANCM TRIP12 TRIM59 BAP1 FBXO10 TRIM9 ZMIZ2 KBTBD13 HERC2 HERC1 CDC20 WDR24	1.31e-05	1074	141	21	GO:0043687
GeneOntologyBiologicalProcess	regulation of norepinephrine secretion	ADRA2A ADRA2B ADRA2C OXTR	2.78e-05	26	141	4	GO:0014061
GeneOntologyBiologicalProcess	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	ADGRG1 ADRA2A ADRA2B ADRA2C ADGRG2 ADGRF5 GPR171 ADGRD2 ADGRL2 ADGRF1	2.81e-05	286	141	10	GO:0007188
GeneOntologyBiologicalProcess	negative regulation of epinephrine secretion	ADRA2A ADRA2B ADRA2C	3.62e-05	10	141	3	GO:0032811
GeneOntologyBiologicalProcess	norepinephrine secretion	ADRA2A ADRA2B ADRA2C OXTR	3.77e-05	28	141	4	GO:0048243
GeneOntologyBiologicalProcess	negative regulation of uterine smooth muscle contraction	ADRA2A ADRA2C	4.64e-05	2	141	2	GO:0070473
GeneOntologyBiologicalProcess	negative regulation of norepinephrine secretion	ADRA2A ADRA2B ADRA2C	4.96e-05	11	141	3	GO:0010700
GeneOntologyBiologicalProcess	regulation of epinephrine secretion	ADRA2A ADRA2B ADRA2C	4.96e-05	11	141	3	GO:0014060
GeneOntologyBiologicalProcess	regulation of body fluid levels	PDGFA LYST FBLN1 ADRA2A ADRA2B ADRA2C OXTR P2RY2 NBEAL2 AKAP11 UBASH3B FERMT3	5.32e-05	442	141	12	GO:0050878
GeneOntologyBiologicalProcess	blood coagulation	PDGFA LYST FBLN1 ADRA2A ADRA2B ADRA2C NBEAL2 UBASH3B FERMT3	7.70e-05	260	141	9	GO:0007596
GeneOntologyBiologicalProcess	epinephrine secretion	ADRA2A ADRA2B ADRA2C	8.51e-05	13	141	3	GO:0048242
GeneOntologyBiologicalProcess	coagulation	PDGFA LYST FBLN1 ADRA2A ADRA2B ADRA2C NBEAL2 UBASH3B FERMT3	9.17e-05	266	141	9	GO:0050817
GeneOntologyBiologicalProcess	hemostasis	PDGFA LYST FBLN1 ADRA2A ADRA2B ADRA2C NBEAL2 UBASH3B FERMT3	9.70e-05	268	141	9	GO:0007599
GeneOntologyBiologicalProcess	norepinephrine transport	ADRA2A ADRA2B ADRA2C OXTR	1.29e-04	38	141	4	GO:0015874
GeneOntologyBiologicalProcess	epinephrine transport	ADRA2A ADRA2B ADRA2C	1.98e-04	17	141	3	GO:0048241
GeneOntologyBiologicalProcess	female pregnancy	LAMB1 FBLN1 ADRA2A ADRA2B ADRA2C OXTR POLR1B NLRP5	3.21e-04	249	141	8	GO:0007565
GeneOntologyBiologicalProcess	regulation of p38MAPK cascade	CYLD GADD45B GADD45A MET	4.39e-04	52	141	4	GO:1900744
GeneOntologyBiologicalProcess	protein ubiquitination	ZSWIM8 KLHL24 TRIM61 UBR4 C10orf90 FANCM TRIP12 TRIM59 FBXO10 TRIM9 KBTBD13 HERC2 HERC1 CDC20 WDR24	4.47e-04	811	141	15	GO:0016567
GeneOntologyBiologicalProcess	melanin biosynthetic process from tyrosine	DCT SLC45A2	4.58e-04	5	141	2	GO:0006583
GeneOntologyBiologicalProcess	regulation of protein modification process	GADD45B DR1 PDGFA WNT9B SPAG9 COPS3 TLR9 GPRC5A FANCM GADD45A MET FBLN1 ADRA2A ADRA2B ADRA2C ZNF592 AKAP11 PRKDC UBASH3B CDC20 C9orf72 WDR24	4.85e-04	1488	141	22	GO:0031399
GeneOntologyBiologicalProcess	negative regulation of catecholamine secretion	ADRA2A ADRA2B ADRA2C	5.01e-04	23	141	3	GO:0033604
GeneOntologyBiologicalProcess	regulation of tube size	WNT9B ADRA2A ADRA2B ADRA2C OXTR P2RY2 KLK2	5.01e-04	203	141	7	GO:0035150
Domain	GPS	ADGRG1 PKD1L3 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	6.63e-09	34	145	7	SM00303
Domain	GPS	ADGRG1 PKD1L3 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	8.24e-09	35	145	7	PF01825
Domain	GPS	ADGRG1 PKD1L3 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	1.02e-08	36	145	7	PS50221
Domain	GPS	ADGRG1 PKD1L3 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	1.25e-08	37	145	7	IPR000203
Domain	Leu-rich_rpt	NLRP11 LRRC32 ZYG11B LRRIQ4 TLR9 NLRP3 FBXL4 LRIG3 NOD1 LRRN2 LRRC14 LRRD1 NLRP13 NLRP5	2.62e-08	271	145	14	IPR001611
Domain	-	NLRP11 LRRC32 ZYG11B LRRIQ4 TLR9 NLRP3 FBXL4 LRIG3 NOD1 LRRN2 LRRC14 LRRD1 NLRP13 NLRP5	2.13e-07	321	145	14	3.80.10.10
Domain	LRR_6	NLRP11 TLR9 NLRP3 NOD1 LRRC14 NLRP13 NLRP5	2.18e-07	55	145	7	PF13516
Domain	L_dom-like	NLRP11 LRRC32 ZYG11B LRRIQ4 TLR9 NLRP3 FBXL4 LRIG3 NOD1 LRRN2 LRRC14 LRRD1 NLRP13 NLRP5	2.77e-07	328	145	14	IPR032675
Domain	NACHT	NLRP11 NLRP3 NOD1 NLRP13 NLRP5	7.91e-07	23	145	5	PS50837
Domain	NACHT_NTPase	NLRP11 NLRP3 NOD1 NLRP13 NLRP5	7.91e-07	23	145	5	IPR007111
Domain	7tm_2	ADGRG1 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	2.37e-06	50	145	6	PF00002
Domain	G_PROTEIN_RECEP_F2_2	ADGRG1 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	2.37e-06	50	145	6	PS00650
Domain	ARM-type_fold	SMG1 UBR4 RTTN XPO4 ZYG11B TRIP12 LYST NBEAL2 ANKAR IQCB1 EFR3B PRKDC TNPO3	2.48e-06	339	145	13	IPR016024
Domain	GPCR_2_secretin-like	ADGRG1 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	7.00e-06	60	145	6	IPR000832
Domain	GPCR_2-like	ADGRG1 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	7.00e-06	60	145	6	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	ADGRG1 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	7.71e-06	61	145	6	PS50261
Domain	ARM-like	SMG1 RTTN XPO4 ZYG11B TRIP12 NBEAL2 ANKAR IQCB1 EFR3B PRKDC TNPO3	8.61e-06	270	145	11	IPR011989
Domain	DAPIN	NLRP11 NLRP3 NLRP13 NLRP5	2.29e-05	22	145	4	PS50824
Domain	PYRIN	NLRP11 NLRP3 NLRP13 NLRP5	2.29e-05	22	145	4	SM01289
Domain	PYRIN	NLRP11 NLRP3 NLRP13 NLRP5	2.29e-05	22	145	4	PF02758
Domain	DAPIN	NLRP11 NLRP3 NLRP13 NLRP5	2.29e-05	22	145	4	IPR004020
Domain	ADR_fam	ADRA2A ADRA2B ADRA2C	5.28e-05	10	145	3	IPR002233
Domain	GPCR_Rhodpsn_7TM	OR5T3 OR8D1 OR9G1 GPR22 OR4D10 OR13F1 OR51A7 ADRA2A ADRA2B ADRA2C OXTR OR56B1 P2RY2 CCR4 GPR171 OR51V1	6.62e-05	670	145	16	IPR017452
Domain	7tm_1	OR5T3 OR8D1 OR9G1 GPR22 OR4D10 OR13F1 OR51A7 ADRA2A ADRA2B ADRA2C OXTR OR56B1 P2RY2 CCR4 GPR171 OR51V1	7.48e-05	677	145	16	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR5T3 OR8D1 OR9G1 GPR22 OR4D10 OR13F1 OR51A7 ADRA2A ADRA2B ADRA2C OXTR OR56B1 P2RY2 CCR4 GPR171 OR51V1	8.58e-05	685	145	16	PS00237
Domain	-	NLRP11 NLRP3 NOD1 LRRD1 NLRP13 NLRP5	8.64e-05	93	145	6	1.10.533.10
Domain	G_PROTEIN_RECEP_F1_2	OR5T3 OR8D1 OR9G1 GPR22 OR4D10 OR13F1 OR51A7 ADRA2A ADRA2B ADRA2C OXTR OR56B1 P2RY2 CCR4 GPR171 OR51V1	9.49e-05	691	145	16	PS50262
Domain	GPCR_Rhodpsn	OR5T3 OR8D1 OR9G1 GPR22 OR4D10 OR13F1 OR51A7 ADRA2A ADRA2B ADRA2C OXTR OR56B1 P2RY2 CCR4 GPR171 OR51V1	9.65e-05	692	145	16	IPR000276
Domain	DEATH-like_dom	NLRP11 NLRP3 NOD1 LRRD1 NLRP13 NLRP5	1.22e-04	99	145	6	IPR011029
Domain	GADD45	GADD45B GADD45A	1.79e-04	3	145	2	IPR024824
Domain	7TM_GPCR_Srsx	OR8D1 ADRA2A ADRA2B ADRA2C OR56B1 CCR4	2.40e-04	112	145	6	SM01381
Domain	GPCR_2_extracellular_dom	ADGRF5 ADGRD2 ADGRL2 ADGRF1	2.56e-04	40	145	4	IPR001879
Domain	G_PROTEIN_RECEP_F2_1	ADGRF5 ADGRD2 ADGRL2 ADGRF1	2.56e-04	40	145	4	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRF5 ADGRD2 ADGRL2 ADGRF1	2.56e-04	40	145	4	PS50227
Domain	LRR_1	LRRC32 LRRIQ4 TLR9 FBXL4 LRIG3 LRRN2 LRRC14 LRRD1	3.17e-04	219	145	8	PF00560
Domain	-	RTTN XPO4 ZYG11B TRIP12 ANKAR EFR3B PRKDC TNPO3	3.47e-04	222	145	8	1.25.10.10
Domain	GPCR_2_Ig-hepta-like_rcpt	ADGRF5 ADGRF1	3.56e-04	4	145	2	IPR008078
Domain	GPR1/GPR3/GPR5	ADGRG1 ADGRG2	3.56e-04	4	145	2	IPR003910
Domain	Autophagy-rel_C	ATG2A VPS13B	5.89e-04	5	145	2	IPR015412
Domain	ATG_C	ATG2A VPS13B	5.89e-04	5	145	2	PF09333
Domain	FATC	SMG1 PRKDC	5.89e-04	5	145	2	PF02260
Domain	PH_BEACH	LYST NBEAL2	8.80e-04	6	145	2	PF14844
Domain	FAT	SMG1 PRKDC	8.80e-04	6	145	2	PS51189
Domain	FATC	SMG1 PRKDC	8.80e-04	6	145	2	PS51190
Domain	FATC_dom	SMG1 PRKDC	8.80e-04	6	145	2	IPR003152
Domain	PIK_FAT	SMG1 PRKDC	8.80e-04	6	145	2	IPR014009
Domain	FATC	SMG1 PRKDC	8.80e-04	6	145	2	SM01343
Domain	LRR	LRRC32 ZYG11B LRRIQ4 TLR9 LRIG3 LRRN2 LRRD1	9.95e-04	201	145	7	PS51450
Domain	HECT	TRIP12 HERC2 HERC1	1.17e-03	27	145	3	PF00632
Domain	HECTc	TRIP12 HERC2 HERC1	1.17e-03	27	145	3	SM00119
Domain	HECT_dom	TRIP12 HERC2 HERC1	1.17e-03	27	145	3	IPR000569
Domain	HECT	TRIP12 HERC2 HERC1	1.17e-03	27	145	3	PS50237
Domain	zf-MIZ	ZMIZ1 ZMIZ2	1.23e-03	7	145	2	PF02891
Domain	ZF_SP_RING	ZMIZ1 ZMIZ2	1.23e-03	7	145	2	PS51044
Domain	Chorein_N	ATG2A VPS13B	1.63e-03	8	145	2	PF12624
Domain	PH-BEACH_dom	LYST NBEAL2	1.63e-03	8	145	2	IPR023362
Domain	VPS13_N	ATG2A VPS13B	1.63e-03	8	145	2	IPR026854
Domain	-	LYST NBEAL2	1.63e-03	8	145	2	2.30.29.40
Domain	Znf_MIZ	ZMIZ1 ZMIZ2	1.63e-03	8	145	2	IPR004181
Domain	PH_BEACH	LYST NBEAL2	1.63e-03	8	145	2	PS51783
Domain	BEACH	LYST NBEAL2	2.08e-03	9	145	2	PS50197
Domain	Beach	LYST NBEAL2	2.08e-03	9	145	2	PF02138
Domain	-	LYST NBEAL2	2.08e-03	9	145	2	1.10.1540.10
Domain	Beach	LYST NBEAL2	2.08e-03	9	145	2	SM01026
Domain	BEACH_dom	LYST NBEAL2	2.08e-03	9	145	2	IPR000409
Domain	LRR_8	LRRC32 LRRIQ4 TLR9 LRIG3 LRRN2 LRRD1	2.20e-03	171	145	6	PF13855
Domain	WD40_repeat_dom	UBR4 SPAG9 LYST WDR87 NBEAL2 HERC1 CDC20 WDR24	2.26e-03	297	145	8	IPR017986
Domain	GPCR_2_secretin-like_CS	ADGRG2 ADGRF5 ADGRL2	2.30e-03	34	145	3	IPR017983
Domain	LRR_TYP	LRRC32 LRRIQ4 TLR9 LRIG3 LRRN2 LRRD1	2.61e-03	177	145	6	SM00369
Domain	Leu-rich_rpt_typical-subtyp	LRRC32 LRRIQ4 TLR9 LRIG3 LRRN2 LRRD1	2.61e-03	177	145	6	IPR003591
Domain	Ribosomal_L7Ae	GADD45B GADD45A	3.14e-03	11	145	2	PF01248
Domain	Ribosomal_L7Ae/L30e/S12e/Gad45	GADD45B GADD45A	3.75e-03	12	145	2	IPR004038
Domain	-	SPAG9 LYST MET WDR87 NBEAL2 HERC1 CDC20 WDR24	4.53e-03	333	145	8	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	SPAG9 LYST MET WDR87 NBEAL2 HERC1 CDC20 WDR24	4.70e-03	335	145	8	IPR015943
Domain	WD40_repeat	LYST WDR87 NBEAL2 HERC2 HERC1 CDC20 WDR24	5.41e-03	272	145	7	IPR001680
Domain	-	GADD45B GADD45A	5.88e-03	15	145	2	3.30.1330.30
Domain	PI3/4_kinase_CS	SMG1 PRKDC	5.88e-03	15	145	2	IPR018936
Domain	L30e-like	GADD45B GADD45A	5.88e-03	15	145	2	IPR029064
Domain	WD_REPEATS_1	LYST WDR87 NBEAL2 HERC2 HERC1 CDC20 WDR24	6.07e-03	278	145	7	PS00678
Domain	WD_REPEATS_2	LYST WDR87 NBEAL2 HERC2 HERC1 CDC20 WDR24	6.19e-03	279	145	7	PS50082
Domain	WD_REPEATS_REGION	LYST WDR87 NBEAL2 HERC2 HERC1 CDC20 WDR24	6.19e-03	279	145	7	PS50294
Domain	-	SMG1 PRKDC	6.69e-03	16	145	2	1.10.1070.11
Domain	PI3Kc	SMG1 PRKDC	6.69e-03	16	145	2	SM00146
Domain	FBOX	FBXL4 FBXO10 FBXL18	7.67e-03	52	145	3	SM00256
Pathway	WP_GPCRS_NONODORANT	ADGRG1 GPRC5A ADRA2A ADRA2B ADRA2C OXTR P2RY2 ADGRG2 CCR4 GPRC5D ADGRL2	5.49e-06	266	107	11	MM15843
Pathway	REACTOME_SURFACTANT_METABOLISM	ADRA2A ADRA2C P2RY2 ADGRF5	2.49e-05	23	107	4	MM15279
Pathway	REACTOME_ADRENOCEPTORS	ADRA2A ADRA2B ADRA2C	3.45e-05	9	107	3	M27302
Pathway	REACTOME_ADRENOCEPTORS	ADRA2A ADRA2B ADRA2C	3.45e-05	9	107	3	MM15009
Pathway	REACTOME_SURFACTANT_METABOLISM	ADRA2A ADRA2C P2RY2 ADGRF5	7.39e-05	30	107	4	M27566
Pathway	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	UBR4 TRIP12 FBXL4 FBXO10 FBXL18 TRIM9 KBTBD13 HERC2 HERC1 CDC20	9.07e-05	299	107	10	MM15711
Pathway	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	UBR4 TRIP12 FBXL4 FBXO10 FBXL18 TRIM9 KBTBD13 HERC2 HERC1 CDC20	1.16e-04	308	107	10	M1070
Pathway	WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE	ADRA2A ADRA2B ADRA2C	2.22e-04	16	107	3	M39849
Pathway	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	UBR4 TRIP12 FBXL4 FBXO10 FBXL18 TRIM9 KBTBD13 HERC2 HERC1 CDC20	2.77e-04	343	107	10	MM15712
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	OR8D1 ADRA2A ADRA2B ADRA2C OXTR P2RY2 CCR4	5.34e-04	186	107	7	MM15994
Pathway	REACTOME_MELANIN_BIOSYNTHESIS	DCT SLC45A2	5.62e-04	5	107	2	M27545
Pathway	REACTOME_MELANIN_BIOSYNTHESIS	DCT SLC45A2	5.62e-04	5	107	2	MM15264
Pathway	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	UBR4 TRIP12 FBXL4 FBXO10 FBXL18 TRIM9 KBTBD13 HERC2 HERC1 CDC20	6.32e-04	381	107	10	M1066
Pubmed	International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.	ADGRG1 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	6.34e-09	33	152	6	25713288
Pubmed	Distribution of mRNA encoding three alpha 2-adrenergic receptor subtypes in the developing mouse embryo suggests a role for the alpha 2A subtype in apoptosis.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	9415717
Pubmed	Direct inhibition of cardiac hyperpolarization-activated cyclic nucleotide-gated pacemaker channels by clonidine.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	17261653
Pubmed	Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	12946937
Pubmed	Resting sympathetic nerve activity is related to age, sex and arterial pressure but not to α2-adrenergic receptor subtype.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	20613626
Pubmed	Nefopam but not physostigmine affects the thermoregulatory response in mice via alpha(2)-adrenoceptors.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	19744502
Pubmed	Function of brain α2B-adrenergic receptor characterized with subtype-selective α2B antagonist and KO mice.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	27751959
Pubmed	Targeting adrenergic receptors to mitigate invariant natural killer T cells-induced acute liver injury.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	37841583
Pubmed	Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	11927164
Pubmed	Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	11125002
Pubmed	Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	12764077
Pubmed	Effect on diurnal intraocular pressure variation of eliminating the alpha-2 adrenergic receptor subtypes in the mouse.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	18326714
Pubmed	Delayed transactivation of the receptor for nerve growth factor is required for sustained signaling and differentiation by alpha2-adrenergic receptors in transfected PC12 cells.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	17215105
Pubmed	Expression of alpha 2-adrenergic receptor subtypes in the mouse brain: evaluation of spatial and temporal information imparted by 3 kb of 5' regulatory sequence for the alpha 2A AR-receptor gene in transgenic animals.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	8843087
Pubmed	Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	17075569
Pubmed	Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	15592690
Pubmed	Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	10385696
Pubmed	Association between common genetic variants of α2A-, α2B-, and α2C-adrenergic receptors and ischemic stroke.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	22560155
Pubmed	Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	10647009
Pubmed	Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	11181434
Pubmed	Insertion/insertion genotype of α(2B)-adrenergic receptor gene polymorphism is associated with silent myocardial ischemia in patients with type 2 diabetes mellitus.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	20692245
Pubmed	Association between Common Genetic Variants of α2A-, α2B-, and α2C-Adrenergic Receptors and Orthostatic Hypotension.	ADRA2A ADRA2B ADRA2C	8.18e-08	3	152	3	26427149
Pubmed	The human and mouse repertoire of the adhesion family of G-protein-coupled receptors.	ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	1.63e-07	29	152	5	15203201
Pubmed	Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response.	ADRA2A ADRA2B ADRA2C	3.26e-07	4	152	3	15920038
Pubmed	The zeta isoform of 14-3-3 proteins interacts with the third intracellular loop of different alpha2-adrenergic receptor subtypes.	ADRA2A ADRA2B ADRA2C	3.26e-07	4	152	3	10224112
Pubmed	The genetics of NOD-like receptors in Crohn's disease.	NLRP11 NLRP3 NLRP13 NLRP5	3.39e-07	14	152	4	20403135
Pubmed	NALPs: a novel protein family involved in inflammation.	NLRP11 NLRP3 NLRP13 NLRP5	3.39e-07	14	152	4	12563287
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ANKRD13D GADD45B UBR4 RTTN ATG2A LYST GADD45A PLEKHM1 PLEKHH3 BAP1 ZNF592 NBEAL2 ZMIZ2 LRRC14 PRKDC HERC2 HERC1 TNPO3 WDR24	3.98e-07	1105	152	19	35748872
Pubmed	Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance.	ADRA2A ADRA2B ADRA2C	8.13e-07	5	152	3	15719258
Pubmed	Interaction of the ubiquitin carboxyl terminal esterase L1 with alpha(2)-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation.	ADRA2A ADRA2B ADRA2C	8.13e-07	5	152	3	19477270
Pubmed	Agonist-regulated Interaction between alpha2-adrenergic receptors and spinophilin.	ADRA2A ADRA2B ADRA2C	8.13e-07	5	152	3	11154706
Pubmed	G(z) signaling: emerging divergence from G(i) signaling.	ADRA2A ADRA2B ADRA2C	8.13e-07	5	152	3	11313909
Pubmed	Interaction of the amyloid precursor like protein 1 with the alpha2A-adrenergic receptor increases agonist-mediated inhibition of adenylate cyclase.	ADRA2A ADRA2B ADRA2C	8.13e-07	5	152	3	16531006
Pubmed	Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.	ADRA2A ADRA2B ADRA2C	8.13e-07	5	152	3	20814988
Pubmed	A novel interaction between adrenergic receptors and the alpha-subunit of eukaryotic initiation factor 2B.	ADRA2A ADRA2B ADRA2C	1.62e-06	6	152	3	9235896
Pubmed	α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.	ADRA2A ADRA2B ADRA2C	1.62e-06	6	152	3	22933299
Pubmed	Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes.	ADRA2A ADRA2B ADRA2C	1.62e-06	6	152	3	17636168
Pubmed	Placental alpha(2)-adrenoceptors control vascular development at the interface between mother and embryo.	ADRA2A ADRA2B ADRA2C	1.62e-06	6	152	3	12068299
Pubmed	Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis.	TLR9 NOD1 PRKDC	1.62e-06	6	152	3	22902233
Pubmed	Association between genetic polymorphisms of adrenergic receptor and diurnal intraocular pressure in Japanese normal-tension glaucoma.	ADRA2A ADRA2B ADRA2C	2.83e-06	7	152	3	20705341
Pubmed	B cell-intrinsic MyD88 signaling controls IFN-γ-mediated early IgG2c class switching in mice in response to a particulate adjuvant.	TLR9 NLRP3 LYZ	2.83e-06	7	152	3	31087643
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SMG1 BRPF3 XPO4 ATG2A BAP1 LRIG3 ZNF592 TRIM9 NBEAL2 EFR3B AKAP11 ADGRL2	4.01e-06	529	152	12	14621295
Pubmed	Cardiac function in genetically engineered mice with altered adrenergic receptor signaling.	ADRA2A ADRA2B ADRA2C	4.51e-06	8	152	3	9139936
Pubmed	Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo.	ADRA2A ADRA2B ADRA2C	6.74e-06	9	152	3	21209093
Pubmed	Downregulation of the Na/K-ATPase pump by leptospiral glycolipoprotein activates the NLRP3 inflammasome.	TLR9 NLRP3 NOD1	9.60e-06	10	152	3	22323544
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	EPRS1 XPO4 COG1 NBEAL2 PRKDC UBASH3B TNPO3	1.69e-05	183	152	7	23956138
Pubmed	Assignment of two alpha 2 adrenoceptor subtype genes to murine chromosomes.	ADRA2A ADRA2B ADRA2C	1.75e-05	12	152	3	8177505
Pubmed	Targeting an Achilles' heel of cancer with a WRN helicase inhibitor.	FANCD2 PRKDC	1.90e-05	2	152	2	24036544
Pubmed	Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks?	ADRA2A ADRA2C	1.90e-05	2	152	2	16636200
Pubmed	An immunocompromised murine model of chronic Bartonella infection.	LYST PRKDC	1.90e-05	2	152	2	20395436
Pubmed	Hematopoietic cells from gadd45a-deficient and gadd45b-deficient mice exhibit impaired stress responses to acute stimulation with cytokines, myeloablation and inflammation.	GADD45B GADD45A	1.90e-05	2	152	2	16732331
Pubmed	Role of Myeloid Cell-Specific TLR9 in Mitochondrial DNA-Induced Lung Inflammation in Mice.	TLR9 LYZ	1.90e-05	2	152	2	36674451
Pubmed	Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c.	ADRA2B ADRA2C	1.90e-05	2	152	2	8670422
Pubmed	Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity.	NLRP3 LYZ	1.90e-05	2	152	2	32367047
Pubmed	Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice.	LYST PRKDC	1.90e-05	2	152	2	9234770
Pubmed	Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure.	ADRA2A ADRA2C	1.90e-05	2	152	2	18632114
Pubmed	Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.	ADRA2A ADRA2C	1.90e-05	2	152	2	1353249
Pubmed	Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice.	LYST PRKDC	1.90e-05	2	152	2	17392156
Pubmed	Double disruption of α2A- and α2C-adrenoceptors induces endothelial dysfunction in mouse small arteries: role of nitric oxide synthase uncoupling.	ADRA2A ADRA2C	1.90e-05	2	152	2	25037566
Pubmed	Signs and lesions of experimental Sendai virus infection in two genetically distinct strains of SCID/beige mice.	LYST PRKDC	1.90e-05	2	152	2	8140728
Pubmed	Identification of an additional gene belonging to the alpha 2 adrenergic receptor family in the human genome by PCR.	ADRA2A ADRA2C	1.90e-05	2	152	2	1849485
Pubmed	Spontaneous and experimental infections in scid and scid/beige mice.	LYST PRKDC	1.90e-05	2	152	2	8320959
Pubmed	Kindlin-3 in platelets and myeloid cells differentially regulates deep vein thrombosis in mice.	LYZ FERMT3	1.90e-05	2	152	2	31477636
Pubmed	Differential involvement of central and peripheral α2 adrenoreceptors in the antinociception induced by aerobic and resistance exercise.	ADRA2A ADRA2C	1.90e-05	2	152	2	23400995
Pubmed	Glutamyl-prolyl-tRNA synthetase 1 coordinates early endosomal anti-inflammatory AKT signaling.	EPRS1 LYZ	1.90e-05	2	152	2	36309524
Pubmed	Hyperactivation of the NLRP3 Inflammasome in Myeloid Cells Leads to Severe Organ Damage in Experimental Lupus.	NLRP3 LYZ	1.90e-05	2	152	2	28039299
Pubmed	α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects.	ADRA2A ADRA2C	1.90e-05	2	152	2	34237656
Pubmed	ALK mutants in the kinase domain exhibit altered kinase activity and differential sensitivity to small molecule ALK inhibitors.	LYST PRKDC	1.90e-05	2	152	2	19249873
Pubmed	Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice.	ADRA2A ADRA2C	1.90e-05	2	152	2	14514350
Pubmed	Characterization of the regulatory regions of murine alpha 2C2 adrenoceptor subtype gene.	ADRA2B ADRA2C	1.90e-05	2	152	2	8762185
Pubmed	Studies of virus-induced myocardial injury in mice: value of the scid mutation on different genetic backgrounds and combined with other mutations.	LYST PRKDC	1.90e-05	2	152	2	8391609
Pubmed	Murine granulated metrial gland cell population in beige (bg/bg) and SCID (scid/scid) genotypes.	LYST PRKDC	1.90e-05	2	152	2	8075241
Pubmed	Human Placenta Expresses α2-Adrenergic Receptors and May Be Implicated in Pathogenesis of Preeclampsia and Fetal Growth Restriction.	ADRA2A ADRA2C	1.90e-05	2	152	2	30273604
Pubmed	SCID-bg mice as xenograft recipients.	LYST PRKDC	1.90e-05	2	152	2	9175014
Pubmed	Nuclear Receptor CAR Suppresses GADD45B-p38 MAPK Signaling to Promote Phenobarbital-induced Proliferation in Mouse Liver.	GADD45B NR1I3	1.90e-05	2	152	2	29716964
Pubmed	The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype.	ADRA2A ADRA2C	1.90e-05	2	152	2	16428542
Pubmed	Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.	ADRA2A ADRA2C	1.90e-05	2	152	2	20083574
Pubmed	Comparison of susceptibility of inbred and outbred infant mice to Escherichia coli heat-stable enterotoxin STa.	LYST PRKDC	1.90e-05	2	152	2	1639480
Pubmed	Ammonia-Induced Brain Edema Requires Macrophage and T Cell Expression of Toll-Like Receptor 9.	TLR9 LYZ	1.90e-05	2	152	2	31401214
Pubmed	Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.	NLRP3 LYZ	1.90e-05	2	152	2	29531021
Pubmed	Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304.	ADRA2A ADRA2B	1.90e-05	2	152	2	10737629
Pubmed	Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis.	GADD45B GADD45A	1.90e-05	2	152	2	34272424
Pubmed	Deletion of the α2A/α2C-adrenoceptors accelerates cutaneous wound healing in mice.	ADRA2A ADRA2C	1.90e-05	2	152	2	25186490
Pubmed	The antiapoptotic factor growth arrest and DNA-damage-inducible 45 beta regulates the nuclear receptor constitutive active/androstane receptor-mediated transcription.	GADD45B NR1I3	1.90e-05	2	152	2	18362160
Pubmed	Translocation of bacteria from the gastrointestinal tract in immunodeficient mice.	LYST PRKDC	1.90e-05	2	152	2	8709573
Pubmed	CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling.	TLR9 CCR4	1.90e-05	2	152	2	18624303
Pubmed	GADD45A and GADD45B as Novel Biomarkers Associated with Chromatin Regulators in Renal Ischemia-Reperfusion Injury.	GADD45B GADD45A	1.90e-05	2	152	2	37511062
Pubmed	Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals.	LYST PRKDC	1.90e-05	2	152	2	8962121
Pubmed	Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.	FANCM FANCD2	1.90e-05	2	152	2	19423727
Pubmed	TRIM59 suppresses the brain ischaemia/reperfusion injury and pyroptosis of microglial through mediating the ubiquitination of NLRP3.	TRIM59 NLRP3	1.90e-05	2	152	2	38291200
Pubmed	Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.	ADRA2A ADRA2B	1.90e-05	2	152	2	14508322
Pubmed	Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells.	LYST PRKDC	1.90e-05	2	152	2	23094018
Pubmed	Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype.	ADRA2B ADRA2C	1.90e-05	2	152	2	2842764
Pubmed	Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice. Brief report.	LYST PRKDC	1.90e-05	2	152	2	8267959
Pubmed	Alpha2-adrenergic receptor activation regulates cortical interneuron migration.	ADRA2A ADRA2C	1.90e-05	2	152	2	22805283
Pubmed	Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice.	ADRA2A ADRA2C	1.90e-05	2	152	2	12384461
Pubmed	Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice.	ADRA2B ADRA2C	1.90e-05	2	152	2	9421280
Pubmed	NLRP3+ macrophages aggravate inflammatory cystitis in diabetes.	NLRP3 LYZ	1.90e-05	2	152	2	36405726
Pubmed	Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release.	MET CCR4	1.90e-05	2	152	2	26070483
Pubmed	Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice.	ADRA2A ADRA2C	1.90e-05	2	152	2	17975126
Interaction	PRDX1 interactions	CYLD ELP1 BAP1 FANCD2 IQCB1 CTBP2 CCR4 PRKDC CDC20 C9orf72 RPA1 FERMT3	1.28e-05	379	139	12	int:PRDX1
Interaction	C3orf18 interactions	SMG1 XPO4 SPAG9 FAR2 COG1 PRKDC TNPO3	1.50e-05	115	139	7	int:C3orf18
Interaction	ELOB interactions	NRBP1 EPRS1 ZSWIM8 INTU ZYG11B COPS3 BAP1 FANCD2 LRRC14 C9orf72 RPA1	1.71e-05	327	139	11	int:ELOB
Interaction	PPM1B interactions	CYLD LRRC32 FANCM TRIM59 FBXL4 FANCD2 HERC2 RPA1 NR1I3	1.94e-05	216	139	9	int:PPM1B
Interaction	DSC1 interactions	CYLD LAMB1 FANCD2 UBASH3B CDC20 C9orf72 RPA1	2.72e-05	126	139	7	int:DSC1
GeneFamily	NLR family	NLRP11 NLRP3 NOD1 NLRP13 NLRP5	3.84e-07	25	111	5	666
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	NLRP11 NLRP3 NLRP13 NLRP5	1.54e-05	25	111	4	994
GeneFamily	Adrenoceptors	ADRA2A ADRA2B ADRA2C	1.84e-05	9	111	3	169
GeneFamily	Adhesion G protein-coupled receptors, subfamily F	ADGRF5 ADGRF1	3.69e-04	5	111	2	916
GeneFamily	Zinc fingers MIZ-type	ZMIZ1 ZMIZ2	7.69e-04	7	111	2	85
GeneFamily	Adhesion G protein-coupled receptors, subfamily G	ADGRG1 ADGRG2	7.69e-04	7	111	2	917
GeneFamily	G protein-coupled receptors, Class C orphans	GPRC5A GPRC5D	7.69e-04	7	111	2	285
GeneFamily	WD repeat domain containing\|BEACH domain containing	LYST NBEAL2	1.31e-03	9	111	2	1230
ToppCell	lymphoid-T_cell-Regulatory_T_cell\|World / Lineage, cell class and subclass	GADD45B ZNF683 ATG2A GADD45A ITGB7 SLC4A10 CCR4 GPR171	3.86e-07	196	152	8	42a4d706382be33d552ece1d0598d073857a8d4e
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	UBR4 ZMIZ1 FAT2 FBXL18 P2RY2 HERC1	3.94e-06	122	152	6	1ed865f0ecfe304fb86313ff51c04e9052357270
ToppCell	lymphoid-T_cell-unlabelled(multiplets)\|World / Lineage, cell class and subclass	NRBP1 GADD45B ZNF683 ATG2A GADD45A CCR4 RABGGTB	5.07e-06	196	152	7	78b006922307c154622d71fcbc79ae5eed3f4b23
ToppCell	lymphoid-T_cell-unlabelled(multiplets)\|T_cell / Lineage, cell class and subclass	NRBP1 GADD45B ZNF683 ATG2A GADD45A CCR4 RABGGTB	5.25e-06	197	152	7	f215435aee15f0ed254104bfd55670144b6d2ac3
ToppCell	lymphoid-T_cell-unlabelled(multiplets)\|lymphoid / Lineage, cell class and subclass	NRBP1 GADD45B ZNF683 ATG2A GADD45A CCR4 RABGGTB	5.25e-06	197	152	7	a224c0a010489ad043bd2ad1385eef33c3b6b792
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRRC32 ITGB7 CYFIP2 CCR4 UBASH3B FERMT3	2.37e-05	167	152	6	eed22d1a17aab84dacb1a488528bae9389644cb9
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC32 TLR9 PKD1L3 ITGB7 MET EFR3B	2.45e-05	168	152	6	04a7810f95196a21325356b42084f96c11af5964
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWDE TRIM59 ITGB7 MYO3A ADRA2A CCR4	2.45e-05	168	152	6	2d2eab3190374f79f373e31c8b062ff4e1766396
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWDE TRIM59 ITGB7 MYO3A ADRA2A CCR4	2.45e-05	168	152	6	df58156721457b34af1e81c0eb8a7243cbbfb303
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GADD45B SALL4 GPRC5A ANKRD61 SLC45A2 C9orf72	2.53e-05	169	152	6	d18b823836ca6fba79a2d2f10cb9966fa2623af2
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GADD45B SALL4 GPRC5A ANKRD61 SLC45A2 C9orf72	2.53e-05	169	152	6	befb9b1618ea30fbf8983bcc493853da53b809c3
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BRPF3 PKD1L3 TRIM59 ITGB7 UBASH3B LY75	2.71e-05	171	152	6	f1fdc0ec3399ed6955976d02be7e5fc329a64276
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OTOP2 ITGB7 ADRA2A ADGRF5 LYZ ADGRF1	2.89e-05	173	152	6	b75353fcbc9f8cdb21d4f10ddbc93a83fd797a3c
ToppCell	facs-Aorta-Heart-3m-Myeloid\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMZ1 LYST ITGB7 CYFIP2 GPR171 FERMT3	2.89e-05	173	152	6	513b4d31bcfb269556c6b4cc389865fb12e52c4f
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMZ1 ITGB7 FNDC7 SLC45A2 GPR171 UBASH3B	3.28e-05	177	152	6	3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMZ1 ITGB7 FNDC7 SLC45A2 GPR171 UBASH3B	3.39e-05	178	152	6	8c5e9fab7b55a654ccaabf2c4d02397399d94616
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AMZ1 ITGB7 FNDC7 SLC45A2 GPR171 UBASH3B	3.50e-05	179	152	6	b7a2429d07d7146b32b3552a5f2a2542105a71e0
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Ly6g5b+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGB7 ADRA2C CD163L1 NBEAL2 LRRN2 CCR4	3.61e-05	180	152	6	5c649e2b3f5a53c0040b69df6e289fb3427ef2db
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AQP11 TRIM59 ZRANB3 TG CDC20 SYNGR4	3.84e-05	182	152	6	3948422707d6d5e021bcd7158e2eb69143613f62
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AQP11 TRIM59 ZRANB3 TG CDC20 SYNGR4	3.84e-05	182	152	6	fe46819c153a81911864473badc794f243705f98
ToppCell	facs-Aorta-Heart-3m-Myeloid-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMZ1 LYST ITGB7 CYFIP2 GPR171 FERMT3	3.95e-05	183	152	6	062ec08d66c923f90fee771b1bf8d98bdc7e6c1b
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-MPO+_mono-neutrophil\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LYST NLRP3 FANCD2 P2RY2 CDC20 LYZ	3.95e-05	183	152	6	01c7f01498a9894920edf8243e41187cbdf90688
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDGFA GSAP GPRC5A NBEAL2 GPRC5D FBN3	4.08e-05	184	152	6	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AMZ1 ITGB7 FNDC7 GPR171 UBASH3B FERMT3	4.20e-05	185	152	6	ed7b26bdebfd0df2b4f5020a855a052d94ae7219
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDGFA GPRC5A TXNDC11 PIGA NBEAL2 FBN3	4.46e-05	187	152	6	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	facs-Trachea-3m-Hematologic-lymphocytic-T_cell-T_cell_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AQP11 ITGB7 CYFIP2 CD163L1 GPR171 FERMT3	4.73e-05	189	152	6	286fcf22a2766cf435cd22f0986b1ca007d5b75a
ToppCell	facs-Trachea-3m-Hematologic-lymphocytic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AQP11 ITGB7 CYFIP2 CD163L1 GPR171 FERMT3	4.73e-05	189	152	6	815631878564b805f3dc30877c5804c3ddb8641b
ToppCell	PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ZNF683 ITGB7 CYFIP2 SLC4A10 CCR4 GPR171	4.73e-05	189	152	6	620d5a71b8cb6288540e2d2d848b9d4d66c1226f
ToppCell	facs-Trachea-3m-Hematologic-lymphocytic-T_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AQP11 ITGB7 CYFIP2 CD163L1 GPR171 FERMT3	4.73e-05	189	152	6	035e5af872fcb8b527fa85dbcaa56e3aaff24531
ToppCell	T_cells-Effector_memory_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	GADD45A NLRP3 SLC4A10 SLC45A2 CACNA1I GPR171	4.87e-05	190	152	6	1af91fe0ee2c924e12f4db93c793e7af475d8f80
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn\|Hippocampus / BrainAtlas - Mouse McCarroll V32	OTOP2 ADRA2B CD163L1 SLC45A2	4.93e-05	59	152	4	ebc80c32b56e97c3ab3ac5ae00f06f7f2bcc3d39
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Camk2d_(CA1_Principal_cells)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	OTOP2 ADRA2B CD163L1 SLC45A2	4.93e-05	59	152	4	719728ed089762ae79cbfbe56c4171d70361a772
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Camk2d_(CA1_Principal_cells)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	OTOP2 ADRA2B CD163L1 SLC45A2	4.93e-05	59	152	4	55954d610f5a813ef15ab5e898c5ad309fc9e319
ToppCell	18-Distal-Immune-Hematopoietic,_T_Cells\|Distal / Age, Tissue, Lineage and Cell class	ZNF683 ITGB7 CYFIP2 SLC4A10 GPR171 FERMT3	5.17e-05	192	152	6	7538c7f63108f357478ea4c5bf27c1f9825b87c7
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	ZNF521 NOD1 CTBP2 ADGRF5 HERC1 ADGRL2	5.79e-05	196	152	6	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	GPRC5A TG EFR3B ADGRD2 LRRD1 FBN3	5.96e-05	197	152	6	4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Basal_3\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	GPRC5A TG EFR3B ADGRD2 LRRD1 FBN3	5.96e-05	197	152	6	2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GPRC5A TG EFR3B ADGRD2 LRRD1 FBN3	5.96e-05	197	152	6	0f37afad46b94c748a149d9ee681472d7a3e6937
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 RTTN ZNF407 PHF3 HERC1 VPS13B	6.30e-05	199	152	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	PSB-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LAMB1 PLEKHH3 MET LRIG3 FBLN1 FAT2	6.30e-05	199	152	6	2add64c3e4cb6384ec381f34c3f1f77e13e3f27c
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	SLF1 LRRC32 ZNF521 ADGRG1 ADGRF5 ADGRL2	6.48e-05	200	152	6	6f531a418ff25b59a543800cf4bce7b72404ce08
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SLF1 LRRC32 ZNF521 ADGRG1 ADGRF5 ADGRL2	6.48e-05	200	152	6	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	SLF1 LRRC32 ZNF521 ADGRG1 ADGRF5 ADGRL2	6.48e-05	200	152	6	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GADD45A TG FANCD2 MET ADRA2A	8.71e-05	131	152	5	81efe8b0ca4377e557a42ddb12aecaf3f46b15bf
Drug	Clonidine	ADRA2A ADRA2B ADRA2C	2.75e-07	3	149	3	DB00575
Drug	Brimonidine	ADRA2A ADRA2B ADRA2C	2.75e-07	3	149	3	DB00484
Drug	Tizanidine	ADRA2A ADRA2B ADRA2C	2.75e-07	3	149	3	DB00697
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	CYLD UBR4 GSAP GPRC5A MET NOD1 AKAP11 PRKDC HERC1 VPS13B	5.43e-07	191	149	10	4168_DN
Drug	Bethanidine	ADRA2A ADRA2B ADRA2C	1.09e-06	4	149	3	DB00217
Drug	2-methoxyidazoxan	ADRA2A ADRA2B ADRA2C	1.09e-06	4	149	3	ctd:C058525
Drug	pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA	GADD45B KLHL24 GPRC5A GADD45A CYFIP2 FBLN1 OXTR ZNF592 ZMIZ2	1.86e-06	170	149	9	978_UP
Drug	Fenoldopam	ADRA2A ADRA2B ADRA2C	2.72e-06	5	149	3	DB00800
Drug	Phenoxybenzamine	ADRA2A ADRA2B ADRA2C	5.41e-06	6	149	3	DB00925
Drug	Xylometazoline	ADRA2A ADRA2B ADRA2C	5.41e-06	6	149	3	DB06694
Drug	xylometazoline	ADRA2A ADRA2B ADRA2C	9.43e-06	7	149	3	ctd:C009695
Drug	Oxymetazoline	ADRA2A ADRA2B ADRA2C	1.50e-05	8	149	3	ctd:D010109
Drug	2gst	PKD1L3 ADGRG2 ADGRF5 ADGRD2 ADGRL2 ADGRF1	2.17e-05	86	149	6	CID000444461
Drug	Norepinephrine	ADRA2A ADRA2B ADRA2C	3.19e-05	10	149	3	DB00368
Drug	Methamphetamine	ADRA2A ADRA2B ADRA2C	3.19e-05	10	149	3	DB01577
Drug	Yohimbine	ADRA2A ADRA2B ADRA2C	3.19e-05	10	149	3	DB01392
Drug	Droxidopa	ADRA2A ADRA2B ADRA2C	3.19e-05	10	149	3	DB06262
Drug	Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A	CYLD KLHL24 ELP1 GSAP GPRC5A LYST GPRC5D LRRC14	3.85e-05	191	149	8	6776_UP
Drug	Napamezol	ADRA2A ADRA2B	4.25e-05	2	149	2	CID000124655
Drug	Pam3cys-oh	SLC45A2 LYZ	4.25e-05	2	149	2	CID000135926
Drug	Wy 27127	ADRA2A ADRA2B	4.25e-05	2	149	2	CID000125697
Drug	Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A	CYLD KLHL24 LAMB1 LYST MET ADGRG2 LYZ VPS13B	4.79e-05	197	149	8	3174_DN
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; PC3; HT_HG-U133A	CYLD KLHL24 PDGFA GSAP LYST PPP1R3D ADGRG2 ZMIZ2	4.79e-05	197	149	8	6686_DN
Drug	Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A	GPR22 ADGRG1 PLEKHH3 FBLN1 NOD1 ZNF592 PHF3 ZMIZ2	4.96e-05	198	149	8	2848_UP
Drug	Ephedra	ADRA2A ADRA2B ADRA2C	5.79e-05	12	149	3	DB01363
Drug	be-6	DCT LYST PRKDC	5.79e-05	12	149	3	CID000449117
Drug	CT-5	GADD45A ADRA2A ADRA2B	7.49e-05	13	149	3	CID003034918
Drug	Lisuride	ADRA2A ADRA2B ADRA2C	9.48e-05	14	149	3	DB00589
Drug	Pramipexole	ADRA2A ADRA2B ADRA2C	9.48e-05	14	149	3	DB00413
Drug	Ropinirole	ADRA2A ADRA2B ADRA2C	9.48e-05	14	149	3	DB00268
Drug	Risperidone	ADRA2A ADRA2B ADRA2C	9.48e-05	14	149	3	DB00734
Disease	Malignant Head and Neck Neoplasm	CYLD FANCM BAP1 FANCD2	6.01e-05	44	142	4	C0278996
Disease	glucose measurement	NRBP1 DR1 OR9G1 ELP1 MYO3A ADRA2A ZMIZ2 CACNA1I HERC1	9.84e-05	380	142	9	EFO_0004468
Disease	suntan, skin pigmentation	SLC45A2 HERC2	1.37e-04	4	142	2	EFO_0003784, EFO_0004279
Disease	response to carbamazepine	INTU TRIM9	1.37e-04	4	142	2	EFO_0008484
Disease	oculocutaneous albinism (implicated_via_orthology)	DCT SLC45A2	2.28e-04	5	142	2	DOID:0050632 (implicated_via_orthology)
Disease	Osteopetrosis	PLEKHM1 FERMT3	2.28e-04	5	142	2	C0029454
Disease	Thymoma	CYLD BAP1	2.28e-04	5	142	2	C0040100
Disease	alkaline phosphatase measurement	DR1 ZMIZ1 PKD1L3 DCT VWDE PLEKHM1 NLRP3 TXNDC11 MYO3A FAR2 IQCB1 UBASH3B LYZ SYNGR4	4.02e-04	1015	142	14	EFO_0004533
Disease	Thymic Carcinoma	CYLD BAP1	4.75e-04	7	142	2	C0205969
Disease	Abnormality of radial ray	SALL4 FANCM FANCD2	5.36e-04	33	142	3	C4228778
Disease	Chloracne	ZNF683 GADD45A RPA1	5.36e-04	33	142	3	C0263454
Disease	Fanconi anemia (implicated_via_orthology)	FANCM FANCD2	6.32e-04	8	142	2	DOID:13636 (implicated_via_orthology)
Disease	Cognition Disorders	MET OXTR SLC4A10	8.14e-04	38	142	3	C0009241
Disease	glucagon measurement	C10orf90 ZRANB3 FBLN1 ADGRL2 NLRP13	9.16e-04	154	142	5	EFO_0008463
Disease	hair colour measurement, eye colour measurement, skin pigmentation measurement	SLC45A2 HERC2	1.01e-03	10	142	2	EFO_0007009, EFO_0007822, EFO_0009764
Disease	pigmentation disease (is_implicated_in)	SLC45A2 HERC2	1.23e-03	11	142	2	DOID:10123 (is_implicated_in)
Disease	hair colour measurement, hair morphology measurement	SLC45A2 HERC2	1.47e-03	12	142	2	EFO_0007821, EFO_0007822
Disease	severe acute respiratory syndrome, COVID-19	ADGRG1 C10orf90 GPRC5A LYST TG FBXO10 SLC4A10 CTBP2	1.50e-03	447	142	8	EFO_0000694, MONDO_0100096
Disease	cognitive function measurement, self reported educational attainment	PKD1L3 PLEKHM1 FBXL4 ZMIZ2 SLC4A10 CACNA1I LRRC14	1.71e-03	355	142	7	EFO_0004784, EFO_0008354
Disease	actinic keratosis	SLC45A2 HERC2	2.01e-03	14	142	2	EFO_0002496
Disease	C-reactive protein measurement	ZSWIM8 OR5T3 DR1 OR9G1 ZMIZ1 TRIP12 NLRP3 CYFIP2 P2RY2 ZMIZ2 POLR1B LYZ TNPO3 TMEM18	2.09e-03	1206	142	14	EFO_0004458
Disease	platelet crit	AMZ1 RTTN ZNF407 NLRP3 P2RY2 POLR1B LRRN2 ADGRD2 UBASH3B LY75 TNPO3 WDR24	2.24e-03	952	142	12	EFO_0007985
Disease	3-hydroxyanthranilic acid measurement	TG ADGRF1	2.32e-03	15	142	2	EFO_0010447
Disease	Drug-induced agranulocytosis	GSAP ADGRL2	2.64e-03	16	142	2	HP_0012235
Disease	neutrophil percentage of leukocytes	COPS3 ZMIZ1 NLRP3 ADRA2A AKAP11 PRKDC UBASH3B LY75 LYZ	2.86e-03	610	142	9	EFO_0007990
Disease	puberty onset measurement	PDGFA CYFIP2 HERC2 TMEM18	3.18e-03	125	142	4	EFO_0005677
Disease	nevus count	GPRC5A SLC45A2	3.35e-03	18	142	2	EFO_0004632
Disease	Bone marrow hypocellularity	FANCM FANCD2	3.35e-03	18	142	2	C1855710
Disease	Tourette syndrome, schizophrenia	PHF3 CACNA1I	3.35e-03	18	142	2	EFO_0004895, MONDO_0005090
Disease	cutaneous melanoma, hair color	LRRN2 SLC45A2 HERC2	3.35e-03	62	142	3	EFO_0000389, EFO_0003924
Disease	response to methotrexate, juvenile idiopathic arthritis	ZMIZ1 CACNA1I	3.73e-03	19	142	2	EFO_0002609, GO_0031427
Disease	skin sensitivity to sun	SLC45A2 HERC2	3.73e-03	19	142	2	EFO_0004795
Disease	synophrys measurement	SUGCT SLC45A2 HERC2	4.35e-03	68	142	3	EFO_0007906
Disease	nose morphology measurement, mouth morphology measurement	SUGCT FBN3	4.55e-03	21	142	2	EFO_0007843, EFO_0007955

Protein segments in the cluster

Peptide	Gene	Start	Entry
CNLLSSQVACLSHIA	SUGCT	241	Q9HAC7
SLVCALLNTCQAHRV	ARSF	11	P54793
ACLSAVDAHSQVCSI	CDC20	391	Q12834
HVLNARITFSNLCGC	ANKRD13D	416	Q6ZTN6
SLLHQLCSCTEAFFL	AMZ1	111	Q400G9
DLLYQSDCVSLHCNL	CTBP2	231	P56545
NQLTSIHADLCQLCL	COPS3	136	Q9UNS2
QDIVTCQCTHLTSFS	ADGRF1	556	Q5T601
DVLFCTSSIVHLCAI	ADRA2C	131	P18825
DQHCSTTRLCNLVFT	FBXO10	171	Q9UK96
LNETICTCSHLTSFG	ADGRG2	596	Q8IZP9
SNVILFCDICNLAVH	BRPF3	226	Q9ULD4
CATHALLSVLLNCSS	BAP1	91	Q92560
RTTCACSHLTNFAIL	ADGRL2	816	O95490
NSLHFCSLNENEIIC	AKAP11	86	Q9UKA4
LDVLFCTSSIVHLCA	ADRA2B	91	P18089
IQATETLAFVHCCLN	CCR4	286	P51679
IQNSSITCLRILCAH	ANKRD61	141	A6NGH8
FSSSSLHLLLCSICQ	CCDC144CP	1206	Q8IYA2
CCHQNLFSAVVTCIL	CD163L1	16	Q9NR16
NQTIDICRHFTNLCL	FBN3	406	Q75N90
HSCADSCALLVNLLQ	ATG2A	1221	Q2TAZ0
SICFSCLLAHAVSLT	GPRC5A	106	Q8NFJ5
NSTLIVLICNDSCLH	OR9G1	41	Q8NH87
NLSCSNTHLNELLLF	OR8D1	186	Q8WZ84
ILDSFTVCNSHVLCI	SPAG9	781	O60271
ALHNRVSIICQLCNA	ANKAR	541	Q7Z5J8
ICHIVLNTTFCLQTQ	NR1I3	201	Q14994
LLSCTNIIFHCAATV	FAR2	101	Q96K12
LRNTSLESCLCSFVH	FAM106C	21	P0CH98
LQCVSLHLLSNDMCA	KLK2	171	P20151
CISHLNNICSLEFSG	LRRD1	436	A4D1F6
AVNACHLSCSALLQD	LYZ	91	P61626
LQQLHLNTSSLLCDC	LRIG3	436	Q6UXM1
CQCSQLSVLDLSHNL	LRRIQ4	231	A6NIV6
TCQLEELHLSGCFFS	NLRP11	831	P59045
AALAVCQCLAVESTH	HERC2	2406	O95714
LEVHCNTSLTQCNFL	FNDC7	326	Q5VTL7
CLQVAFADAHTQLAC	LRRN2	596	O75325
LHISRAALFCNTLVC	FANCM	96	Q8IYD8
LLAFCHINNISENSS	HERC1	996	Q15751
LETQALTQCCLHSDY	FAT2	3936	Q9NYQ8
ALNTCVSHICAVLTF	OR51A7	236	Q8NH64
SFCLHQDLLRLACSD	OR51V1	186	Q9H2C8
ACHCQSINLFVESFL	EFR3B	86	Q9Y2G0
AFVSIDRCLQLTHSC	GPR171	106	O14626
NEIEHCLCSNLGVTS	OR56B1	181	Q8NGI3
NACSADCSALSFVLH	NOD1	686	Q9Y239
NFTSCSERHFVSLCQ	LY75	1076	O60449
SISALLHQTGLACEC	LAMB1	761	P07942
ILDLCHSFCSLVSQN	TUBGCP4	586	Q9UGJ1
LLLTTHSHTCQCFCL	ELP1	651	O95163
QNLDLIASSFCLQHC	NLRP5	716	P59047
LFHELVQRFLCCSAS	OXTR	336	P30559
FTHLLNISEALQQCC	CYFIP2	626	Q96F07
NCCTEFIHLISSEAN	DR1	41	Q01658
FRSLDLSCHTLNAIN	P2RY2	271	P41231
CSTACAHTNVTLALA	ITGB7	666	P26010
CTQILSALSYLHSCD	NRBP1	181	Q9UHY1
LTFTNLDALHTLSAC	OTOP2	446	Q7RTS6
HQCCLSIRAVFQQTL	INTU	836	Q9ULD6
CCTGFLAITSQLHQV	RABGGTB	196	P53611
HLNLSRNSLTCISDF	LRRC32	201	Q14392
EHLTSLCFLNLSRNC	LRRC32	336	Q14392
TFTDLLQTLEHLCSN	METTL21A	151	Q8WXB1
TGIHNCSINETCFNI	FBLN1	531	P23142
LSSNCVCQIHRFIVN	RPA1	71	P27694
LTLCVFTNHTGSLCV	GSAP	281	A4D1B5
CNCLGIQRFADTHSL	KLHL24	166	Q6TFL4
EASQCLHATQLYLLC	COG1	136	Q8WTW3
FQAHLGCLQNSVLCS	LINC01555	76	Q8NAE3
ALCFSCLLAHASNLV	GPRC5D	101	Q9NZD1
ELSCSHFLNETCLEV	FBXL4	381	Q9UKA2
DHCLCSFCLSLLQEQ	CPHXL2	266	A0A1W2PPK0
LQIHFTLIQAFCCEN	GADD45A	71	P24522
LQIHFTLIQSFCCDN	GADD45B	71	O75293
CTHDERSCLSSLQFV	CACNA1I	1691	Q9P0X4
CEDILFSFHSCLQLA	C1orf112	211	Q9NSG2
FLSDSCCTLHQLYLQ	C1orf112	266	Q9NSG2
ASSLLCFQHQEESLA	ADGRG1	116	Q9Y653
AVCAHQCLRLLQQAS	LYST	551	Q99698
SQLTQILSHCCVGLE	IQCB1	81	Q15051
FSSSSLHLLLCSICQ	CCDC144A	1396	A2RUR9
CSFACVESTILLHIN	CYLD	286	Q9NQC7
FFCHSQTDLLALSQA	FAM237A	31	A0A1B0GTK4
SLESNTALICCFHEA	GPR22	106	Q99680
NECLICHRVLSCQSS	SALL4	566	Q9UJQ4
FSALVLTLCFTVHLC	SLC45A2	221	Q9UMX9
LNAISSHLQTCGCSV	C9orf72	221	Q96LT7
QCTQVTSLLQLVHSC	FANCD2	606	Q9BXW9
AISCSDTHTNQLLLF	OR5T3	216	Q8NGG3
RAFSTCSAHLIAILC	OR10D3	236	Q8NH80
LSLCGNSIINHFTCE	OR13F1	166	Q8NGS4
FLLHNLSIADICFSS	OR4D10	61	Q8NGI6
SSFCIENCHRVESLS	NLRP3	666	Q96P20
FTVACQHRSNSEIIC	MET	786	P08581
LSNEEHTCVENCSLL	PLEKHM1	566	Q9Y4G2
HRLALQSVSCLQQLC	RTTN	246	Q86VV8
SCDSFTSTINELNHC	EPRS1	91	P07814
SALSQRQELLCTVHC	PLEKHH3	396	Q7Z736
ETLVASCCNLRHLNL	FBXL18	376	Q96ME1
SQLSCHLDVVTCLAL	NBEAL2	2496	Q6ZNJ1
EDVNICLQACSSLHA	SMG1	771	Q96Q15
STILRTQCLCNHLTF	PKD1L3	656	Q7Z443
SALLCTAQHLAAVQS	RIOX1	146	Q9H6W3
ALDVLFCTSSIVHLC	ADRA2A	126	P08913
FCTSSIVHLCAISLD	ADRA2A	131	P08913
CFCNHSTSFAILLQI	ADGRD2	631	Q7Z7M1
DNVTCICDHLTSFSI	ADGRF5	981	Q8IZF2
TELEIQNSCSTIHCL	CCDC54	141	Q8NEL0
FLATFQLCCCTHELQ	AQP11	51	Q8NBQ7
QLCCCTHELQLLSEQ	AQP11	56	Q8NBQ7
LVFSSCVHLRVSQQC	C10orf90	246	Q96M02
LTVSLCDTNHIICVS	PIGA	171	P37287
VTRLECSCTISAHFN	TRIM61	181	Q5EBN2
ALSSCHVDLLQTSSC	VWDE	351	Q8N2E2
ICLNFLTTHLEKFCS	ZYG11B	21	Q9C0D3
ELFSSFVNCLTHLTC	XPO4	366	Q9C0E2
LEEHLECACATTSLN	PDGFA	171	P04085
SHLQCLRLSHNCISQ	TLR9	496	Q9NR96
NFCHSLQCDNLLSSQ	SCML2	451	Q9UQR0
FLEHNLTSDNCALLC	KBTBD13	96	C9JR72
VHSCDSCLQVFESLS	ZNF521	46	Q96K83
HQVDSSTAQCLLCGL	ZNF592	1146	Q92610
HNDLELLTQYSCNCV	SLC4A10	656	Q6U841
HELNCSLLSETCVTI	PHF3	251	Q92576
LCCSSQDLEFTLHCL	PPP1R3D	141	O95685
TLRSLNITDNCVIHC	TMUB2	226	Q71RG4
HINVAFSCVSASCRI	FERMT3	616	Q86UX7
HCILNSNSVACSFAV	SYNGR4	56	O95473
CDSLDDYNHLVTLCN	DCT	286	P40126
RSCLFNESFCHQISE	SLF1	511	Q9BQI6
SCIQDISCQHAALLS	PRKDC	2856	P78527
TVTACCCSHLFVLQL	ZMIZ2	526	Q8NF64
QSLEDALFHCRLCSQ	ZBTB39	531	O15060
LQLEECCTHNNSATL	TRIM9	446	Q9C026
QQLVSQLLHTCCFCL	TNPO3	831	Q9Y5L0
SFSRTHNVCELCVNQ	TXNDC11	461	Q6PKC3
VALCLFRIHNASAVC	ZSWIM8	201	A7E2V4
HLTLQLEVQSCCVFI	VPS13B	1066	Q7Z7G8
HASSLEACTCQLQGL	UBASH3B	576	Q8TF42
CDECNFASTTQSHLT	ZNF407	1716	Q9C0G0
SCLNQASTTLHVNCS	WDR24	706	Q96S15
DTQSRLVAFSCHCQV	WNT9B	321	O14905
FLFNQCICIHLKSNT	POLR1B	326	Q9H9Y6
STCLCFARLVDNFQH	TRIP12	621	Q14669
FCSIDCTTILQLHEI	UBR4	1101	Q5T4S7
LSECSQHEACLITTL	TG	2131	P01266
HLCAITSFDVCLSLS	WDR87	566	Q6ZQQ6
LATFHALCVLLTCLS	TMEM18	31	Q96B42
SHTFCRNCLENILQA	TRIM59	26	Q8IWR1
QCALCQKSFTQLAHL	ZNF683	351	Q8IZ20
ITVTACCCSHLFVLQ	ZMIZ1	666	Q9ULJ6
QCSLDNLQTLCTVCH	ZRANB3	1031	Q5FWF4
FQQLLQECAHCSRAL	LRRC14	61	Q15048
SCQDLALFLTSIQHV	NLRP13	826	Q86W25
NLTTACCQHLFSVLS	NLRP13	991	Q86W25
ISNHTALENCASLLC	MYO3A	626	Q8NEV4